MG

Publications

Automatically fetched from Scopus, deduplicated by DOI, grouped by year.

Publications
62
Citations
974
h-index
19
Showing 62 items
at publicationcurrent JCR year

2026

  • Unraveling the telomere-mitochondrial axis in colorectal cancer: Results from a prospectively followed cohort
    2026Molecular MedicineDOI10.1186/s10020-026-01423-6Cited by: 1Scopus
    Biochemistry & molecular biology Q1
    Cell biology Q1
    Medicine, research & experimental Q1
    Article
    8.3
    IF 2025
  • Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape
    2026Molecular CancerDOI10.1186/s12943-026-02697-4Cited by: 0Scopus
    Review
    n.d.
    No JCR data
  • Editorial: Deciphering molecular mechanisms behind tumor heterogeneity features by using nucleic acid-based technologies
    2026Frontiers in GeneticsDOI10.3389/fgene.2026.1917362Cited by: 0Scopus
    Genetics & heredity Q2
    Editorial
    3.0
    IF 2025
  • Correction: Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis
    2026Frontiers in MedicineDOI10.3389/fmed.2026.1824707Cited by: 1Scopus
    Medicine, general & internal Q1
    Erratum
    3.6
    IF 2025
  • Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives
    2026Digestive and Liver DiseaseDOI10.1016/j.dld.2026.03.002Cited by: 1Scopus
    Gastroenterology & hepatology Q1
    Review
    4.9
    IF 2025
  • Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis
    2026Frontiers in MedicineDOI10.3389/fmed.2026.1742644Cited by: 1Scopus
    Medicine, general & internal Q1
    Review
    3.6
    IF 2025

2025

  • Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2025.06.001Cited by: 3Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2025.05.005Cited by: 5Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2025.03.004Cited by: 9Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2025.03.005Cited by: 16Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • Sex Disparities and Female Reproductive and Hormonal Factors Associated with Risk of Pancreatic Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort
    2025CancersDOI10.3390/cancers17142275Cited by: 4Scopus
    Oncology Q2
    Article
    4.8
    IF 2025
  • Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2025.02.009Cited by: 29Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • Author's Reply: Comment on “Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma”
    2025Digestive and Liver DiseaseDOI10.1016/j.dld.2024.12.025Cited by: 0Scopus
    Gastroenterology & hepatology Q1
    Letter
    4.9
    IF 2025
  • Genetic landscape for screening and early diagnosis of pancreatic ductal adenocarcinoma: is there a signature?
    2025Best Practice and Research Clinical GastroenterologyDOI10.1016/j.bpg.2025.101988Cited by: 2Scopus
    Gastroenterology & hepatology Q1
    Review
    5.2
    IF 2025
  • Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer
    2025Seminars in Cancer BiologyDOI10.1016/j.semcancer.2024.12.005Cited by: 10Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
  • Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization
    2025International Journal of CancerDOI10.1002/ijc.35196Cited by: 3Scopus
    Oncology Q2
    Article
    4.9
    IF 2025
  • Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review
    2025MutagenesisDOI10.1093/mutage/gead034Cited by: 8Scopus
    Genetics & heredity Q2
    Toxicology Q2
    Review
    3.1
    IF 2025
  • Mitochondrial DNA abundance in blood is associated with Alzheimer’s disease- and dementia-risk
    2025Molecular PsychiatryDOI10.1038/s41380-024-02670-xCited by: 14Scopus
    Biochemistry & molecular biology Q1
    Neurosciences Q1
    Psychiatry Q1
    Article
    10.4
    IF 2025
  • A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy
    2025CancerDOI10.1002/cncr.35678Cited by: 4Scopus
    Oncology Q1
    Article
    5.6
    IF 2025
  • A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma
    2025MutagenesisDOI10.1093/mutage/geae012Cited by: 0Scopus
    Genetics & heredity Q2
    Toxicology Q2
    Article
    3.1
    IF 2025

2024

  • Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome
    2024Blood Cancer JournalDOI10.1038/s41408-024-01181-wCited by: 2Scopus
    Hematology Q1
    Oncology Q1
    Letter
    13.8
    IF 2025
    11.6 in 2024
  • Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk
    2024Human GenomicsDOI10.1186/s40246-024-00576-xCited by: 7Scopus
    Genetics & heredity Q1 → Q2
    Article
    4.1
    IF 2025
    4.3 in 2024
  • Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk
    2024International Journal of CancerDOI10.1002/ijc.35046Cited by: 4Scopus
    Oncology Q1 → Q2
    Article
    4.9
    IF 2025
    4.7 in 2024
  • Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma
    2024Digestive and Liver DiseaseDOI10.1016/j.dld.2023.10.015Cited by: 11Scopus
    Gastroenterology & hepatology Q2 → Q1
    Article
    4.9
    IF 2025
    3.8 in 2024
  • Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study
    2024Journal of the Endocrine SocietyDOI10.1210/jendso/bvae017Cited by: 14Scopus
    Endocrinology & metabolism Q2
    Article
    4.4
    IF 2025
    3.1 in 2024
  • Association of hypothyroidism with survival in pancreatic cancer: Retrospective cohort study
    2024Bjs OpenDOI10.1093/bjsopen/zrad119Cited by: 1Scopus
    Surgery Q1
    Article
    4.9
    IF 2025
    4.5 in 2024

2023

  • Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
    2023Biological ResearchDOI10.1186/s40659-023-00457-yCited by: 2Scopus
    Biology Q1
    Article
    5.4
    IF 2025
    4.3 in 2023
  • Polymorphic variants involved in methylation regulation: A strategy to discover risk loci for pancreatic ductal adenocarcinoma
    2023Journal of Medical GeneticsDOI10.1136/jmg-2022-108910Cited by: 19Scopus
    Genetics & heredity Q2
    Article
    3.4
    IF 2025
    3.6 in 2023
  • Genetic and non-genetic risk factors for early-onset pancreatic cancer
    2023Digestive and Liver DiseaseDOI10.1016/j.dld.2023.02.023Cited by: 29Scopus
    Gastroenterology & hepatology Q1
    Article
    4.9
    IF 2025
    4.0 in 2023
  • A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma
    2023CarcinogenesisDOI10.1093/carcin/bgad056Cited by: 7Scopus
    Oncology Q2
    Article
    3.8
    IF 2025
    3.3 in 2023
  • Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk
    2023International Journal of CancerDOI10.1002/ijc.34383Cited by: 18Scopus
    Oncology Q1 → Q2
    Article
    4.9
    IF 2025
    5.7 in 2023
  • The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer
    2023Critical Reviews in Oncology HematologyDOI10.1016/j.critrevonc.2023.104020Cited by: 31Scopus
    Hematology Q1
    Oncology Q1
    Review
    6.2
    IF 2025
    5.5 in 2023
  • Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
    2023Frontiers in OncologyDOI10.3389/fonc.2023.1172606Cited by: 20Scopus
    Oncology Q2
    Article
    3.4
    IF 2025
    3.5 in 2023

2022

  • Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women
    2022Scientific ReportsDOI10.1038/s41598-022-22973-9Cited by: 18Scopus
    Multidisciplinary sciences Q2 → Q1
    Article
    4.9
    IF 2025
    4.6 in 2022
  • Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset
    2022NeuroendocrinologyDOI10.1159/000524659Cited by: 11Scopus
    Endocrinology & metabolism Q2 → Q3
    Neurosciences Q2 → Q3
    Article
    2.4
    IF 2025
    4.1 in 2022
  • TAS2R38 polymorphisms, Helicobacter pylori infection and susceptibility to gastric cancer and premalignant gastric lesions
    2022European Journal of Cancer PreventionDOI10.1097/CEJ.0000000000000722Cited by: 2Scopus
    Oncology Q4 → Q3
    Article
    2.5
    IF 2025
    2.4 in 2022
  • A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs
    2022CarcinogenesisDOI10.1093/carcin/bgac051Cited by: 15Scopus
    Oncology Q2
    Article
    3.8
    IF 2025
    4.7 in 2022
  • Genome-wide association study of mitochondrial copy number
    2022Human Molecular GeneticsDOI10.1093/hmg/ddab341Cited by: 6Scopus
    Genetics & heredity Q2
    Biochemistry & molecular biology Q3
    Article
    3.1
    IF 2025
    3.5 in 2022
  • In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration
    2022International Journal of Molecular SciencesDOI10.3390/ijms23073775Cited by: 12Scopus
    Biochemistry & molecular biology Q1
    Chemistry, multidisciplinary Q2
    Article
    5.6
    IF 2025
    5.6 in 2022
  • Germline genetic variability in pancreatic cancer risk and prognosis
    2022Seminars in Cancer BiologyDOI10.1016/j.semcancer.2020.08.003Cited by: 57Scopus
    Oncology Q1
    Review
    20.3
    IF 2025
    14.5 in 2022

2021

  • Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
    2021Frontiers in OncologyDOI10.3389/fonc.2021.771312Cited by: 12Scopus
    Oncology Q2
    Article
    3.4
    IF 2025
    5.738 in 2021
  • Polymorphic variants in Sweet and Umami taste receptor genes and birthweight
    2021Scientific ReportsDOI10.1038/s41598-021-84491-4Cited by: 6Scopus
    Multidisciplinary sciences Q2 → Q1
    Article
    4.9
    IF 2025
    4.997 in 2021
  • Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
    2021Scientific ReportsDOI10.1038/s41598-021-87130-0Cited by: 3Scopus
    Multidisciplinary sciences Q2 → Q1
    Article
    4.9
    IF 2025
    4.997 in 2021
  • Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk
    2021Cancer Epidemiology Biomarkers and PreventionDOI10.1158/1055-9965.EPI-21-0353Cited by: 9Scopus
    Public, environmental & occupational health Q2 → Q1
    Oncology Q3 → Q2
    Article
    3.7
    IF 2025
    4.09 in 2021
  • Association between telomere length and mitochondrial copy number and cancer risk in humans: A meta-analysis on more than 300,000 individuals
    2021Critical Reviews in Oncology HematologyDOI10.1016/j.critrevonc.2021.103510Cited by: 27Scopus
    Hematology Q1
    Oncology Q1
    Review
    6.2
    IF 2025
    6.625 in 2021
  • Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: A pathway analysis of genome-wide association studies
    2021American Journal of Clinical NutritionDOI10.1093/ajcn/nqab217Cited by: 21Scopus
    Nutrition & dietetics Q1
    Article
    7.1
    IF 2025
    8.472 in 2021
  • Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
    2021Frontiers in GeneticsDOI10.3389/fgene.2021.693933Cited by: 19Scopus
    Genetics & heredity Q1 → Q2
    Article
    3.0
    IF 2025
    4.772 in 2021
  • Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma
    2021CarcinogenesisDOI10.1093/carcin/bgab057Cited by: 26Scopus
    Oncology Q2
    Article
    3.8
    IF 2025
    4.741 in 2021
  • Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility
    2021International Journal of CancerDOI10.1002/ijc.33475Cited by: 38Scopus
    Oncology Q1 → Q2
    Article
    4.9
    IF 2025
    7.316 in 2021
  • Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
    2021Journal of Medical GeneticsDOI10.1136/jmedgenet-2020-106961Cited by: 59Scopus
    Genetics & heredity Q1 → Q2
    Article
    3.4
    IF 2025
    5.945 in 2021
  • Telomere length and male fertility
    2021International Journal of Molecular SciencesDOI10.3390/ijms22083959Cited by: 32Scopus
    Biochemistry & molecular biology Q1
    Chemistry, multidisciplinary Q2
    Article
    5.6
    IF 2025
    6.208 in 2021

2020

  • Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer
    2020Journal of Medical GeneticsDOI10.1136/jmedgenet-2019-106200Cited by: 69Scopus
    Genetics & heredity Q1 → Q2
    Article
    3.4
    IF 2025
    6.318 in 2020
  • Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction
    2020Scientific ReportsDOI10.1038/s41598-020-63790-2Cited by: 8Scopus
    Multidisciplinary sciences Q1
    Article
    4.9
    IF 2025
    4.38 in 2020
  • Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
    2020JAMA Network OpenDOI10.1001/jamanetworkopen.2020.22933Cited by: 39Scopus
    Medicine, general & internal Q1
    Article
    11.7
    IF 2025
    8.485 in 2020
  • Genome-wide association study identifies an early onset pancreatic cancer risk locus
    2020International Journal of CancerDOI10.1002/ijc.33004Cited by: 29Scopus
    Oncology Q1 → Q2
    Article
    4.9
    IF 2025
    7.396 in 2020
  • Mitochondrial DNA copy-number variation and pancreatic cancer risk in the prospective EPIC cohort
    2020Cancer Epidemiology Biomarkers and PreventionDOI10.1158/1055-9965.EPI-19-0868Cited by: 25Scopus
    Public, environmental & occupational health Q1
    Oncology Q2
    Article
    3.7
    IF 2025
    4.254 in 2020

2019

  • Genetic variants in taste-related genes and risk of pancreatic cancer
    2019MutagenesisDOI10.1093/mutage/gez032Cited by: 18Scopus
    Genetics & heredity Q2
    Toxicology Q2
    Article
    3.1
    IF 2025
    3.379 in 2019
  • Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: A two-phase study on more than 14 000 individuals
    2019MutagenesisDOI10.1093/mutage/gez040Cited by: 16Scopus
    Genetics & heredity Q2
    Toxicology Q2
    Article
    3.1
    IF 2025
    3.379 in 2019
  • Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patients
    2019CarcinogenesisDOI10.1093/carcin/bgz006Cited by: 12Scopus
    Oncology Q2
    Article
    3.8
    IF 2025
    4.603 in 2019

2017

  • Taste receptor polymorphisms and male infertility
    2017Human ReproductionDOI10.1093/humrep/dex305Cited by: 40Scopus
    Obstetrics & gynecology Q1
    Reproductive biology Q1
    Article
    6.8
    IF 2025
    4.99 in 2017

2016

  • Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors
    2016Scientific ReportsDOI10.1038/srep39565Cited by: 20Scopus
    Multidisciplinary sciences Q1
    Article
    4.9
    IF 2025
    4.259 in 2016
  • Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk
    2016OncotargetDOI10.18632/oncotarget.10935Cited by: 49Scopus
    Article
    5.168
    IF 2016